Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Addiction

  • U.S. State Attorneys General Probe Opioid Drug Companies

    A bipartisan group of state attorneys general has announced that they are jointly investigating the marketing and...
  • U.S. State, Local Government Lawsuits over Opioids Face Uphill Battle

    A growing number of U.S. states, counties and cities are filing lawsuits accusing drug companies of deceptively...
  • ED Opioid Guidelines Tied to Fewer Prescriptions in Ohio

    Ohio’s emergency department (ED) guidelines for reducing inappropriate prescribing are linked to a drop in opioid dispensing,...

U.S. State Attorneys General Probe Opioid Drug Companies

June 27, 2017 - Nate Raymond (Reuters) - 0 Comment

A bipartisan group of state attorneys general has announced that they are jointly investigating the marketing and…

Read More

U.S. State, Local Government Lawsuits over Opioids Face Uphill Battle

June 12, 2017 - Nate Raymond (Reuters) - 0 Comment

A growing number of U.S. states, counties and cities are filing lawsuits accusing drug companies of deceptively…

Read More

ED Opioid Guidelines Tied to Fewer Prescriptions in Ohio

June 7, 2017 - Marilynn Larkin (Reuters Health) - 0 Comment

Ohio’s emergency department (ED) guidelines for reducing inappropriate prescribing are linked to a drop in opioid dispensing,…

Read More

Opinion: Dangers of Marijuana Experienced Firsthand

May 15, 2017 - Brad Roberts, MD - 9 Comments

I recently finished my residency in emergency medicine and began to practice in Pueblo, Colorado. I grew…

Read More

U.S. Senator Launches Probe into Five Top Opioid Drugmakers

April 18, 2017 - Reuters Staff (Reuters) - 1 Comment

U.S. Democratic Senator Claire McCaskill has sought details from the nation’s top opioid drugmakers on their sales…

Read More

Psychiatric Inpatients at Higher Risk of Death after Discharge

April 11, 2017 - Marilynn Larkin - 0 Comment

NEW YORK (Reuters Health) – Individuals discharged from inpatient psychiatric care are 16 times more likely to…

Read More

U.S. Senators Question Kaleo’ $4,500 Tag on Opioid Overdose Treatment

March 6, 2017 - Ankur Banerjee - 0 Comment

(Reuters) – U.S. Democrat Senator Claire McCaskill has asked Kaleo Pharmaceuticals to justify the more than 550…

Read More

Patient Education Might Help Lower Risk of Prescription Opioid Abuse

December 27, 2016 - Will Boggs, MD - 0 Comment

(Reuters Health) – Patients who talk with their physicians about the risks of prescription opioid addiction are…

Read More

U.S. DEA Temporarily Bans Synthetic Opioid “Pink” after 46 Deaths

December 13, 2016 - Natalie Grover - 0 Comment

(Reuters) – The U.S. Drug Enforcement Administration (DEA) said on Thursday it had temporarily categorized a synthetic…

Read More

FDA Warning for Opioids, Benzodiazepines, Experimental Drug for Alzheimer’s Is Promising, and More

November 14, 2016 - Eric J. Morley, MD, MS, department of emergency medicine, Stony Brook School of Medicine, New York - 0 Comment

FDA Requires Boxed Warning, Medication Guides for Opioids, Benzodiazepines The prescription of opioids and benzodiazepines in combination…

Read More
  • «
  • ‹
  • 3
  • 4
  • 5
  • 6
  • 7
  • ›
  • »

Current Issue

ACEP Now: November 2025

Download PDF

Read More

Polls

Which topic would you like to see ACEP Now tackle?

View Results

Loading ... Loading ...
  • Polls Archive
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603